Research means doing a study in order to learn something new or answer a question, then sharing the answers with others. Clinical research refers to studies on human patients. Pediatric blood and cancer specialists have relied on clinical research to make great advances in treatment. Without families willing to participate in clinical research studies during treatment, it would be impossible to answer key questions about how to best treat children with cancer and blood disorders.
New research studies build on the results of past research studies and current treatments. Research studies are the building blocks of medical breakthroughs and cures.
Research can help to improve the health, medical care and quality of people’s lives. Some examples include:
- New drugs or therapies to help treat childhood cancer and other illnesses.
- New ways to do surgery that are safer and help the body to heal more quickly.
- New technology that helps find childhood cancer and other illnesses sooner.
Taking part in clinical research is always voluntary. Your child does not have to take part in a clinical research study to be treated at the Aflac Cancer and Blood Disorders Center. Your choice will not affect how the Aflac Cancer Center staff feels about or treats you or your child. Your child will still get the same quality of care.
Find a Clinical Trial
Visit our new online clinical trials database.
This tools allows you to easily search and view our open clinical trials. Here you will find a brief summary of each trial, objectives and eligibility criteria.
How Does Your Child Benefit from Pediatric Clinical Research?
Children treated on pediatric clinical trials may benefit by getting the:
- Most up-to-date treatment available.
- Close follow-up that clinical trials require.
But there may not be a direct benefit to your child. Benefits will vary among different studies. In some cases, such as taking part in a registry, your child will not get any direct benefit. Instead, other children in the future may benefit from what is learned from your child’s data.
Your doctor can answer questions about the possible benefits of taking part in a clinical research study. Please talk with your child, your child’s doctor, your family members and others before deciding to take part in research.
Some questions you may want to ask about a treatment include:
- Which treatment do you advise and why?
- What is the chance that the treatment will work?
- How will we know if the treatment works?
- What are the risks of the treatment?
- How long will the treatment last?
- What do I need to do as a part of a research study that is different from the care my child would usually get?
- How much will the treatment cost, and who pays for the cost?
- How can I help prepare my child for the treatment?
- What are other alternatives?
- The Aflac Cancer Center currently has 65 studies open through COG and ranks among the top institutions nationally for clinical trial enrollment
- The Aflac Cancer Center is one of 14 universities and children's hospitals with exclusive access to Phase I and Phase II neuroblastoma clinical trials
Clinical Trial Collaboration
The Aflac Cancer Center conducts leading-edge pediatric cancer research in conjunction with:
Areas of Focus
Working together, Children's and Emory University School of Medicine have developed a robust laboratory research program. Specific areas of research include:
- Molecular aspects of developing novel treatments and key gene products that target childhood cancer
- Recombinant immunotoxins (RITs) and antisense DNA for therapy of drug resistance
- A better understanding of the body's immune system and how to harness it to fight cancer-with and without a blood and marrow transplant (BMT)
- Gene insertion therapy
- Stem cell plasticity
Our research programs continue to grow, with more faculty and increasing National Institutes of Health (NIH) funding each year.
More information about pediatric research at the Aflac Cancer Center